Article Text

Download PDFPDF
Endovascular recanalisation of a chronic occlusion of the retrohepatic IVC associated to a filter in a patient with antiphospholipid syndrome
  1. Carlos A Hinojosa,
  2. Rene Lizola,
  3. Hugo Laparra-Escareno,
  4. Javier E Anaya-Ayala
  1. Surgery, Section of Vascular Surgery and Endovascular Therapy, Instituto Nacional de Ciencias Medicas y Nutricion ‘Salvador Zubiran’, Mexico, Mexico
  1. Correspondence to Professor Carlos A Hinojosa, carlos.a.hinojosa{at}


Inferior vena cava (IVC) filters are useful adjuncts to prevent venous thromboembolism to the pulmonary circulation in the setting of contraindication for anticoagulation. Despite their proven decreased rate of pulmonary embolism, IVC filters are not without complications. We herein present the case of a 22-year-old man with a history of antiphospholipid antibody syndrome who was sent to our institution for evaluation with Budd-Chiari and post-thrombotic syndromes associated to a chronic retrohepatic complete IVC occlusion secondary to an IVC filter placed 5 years earlier. Via common femoral, transjugular and transhepatic accesses, we performed a successful endovascular recanalisation and reconstruction of the IVC with a 16 mm×60 mm covered stent; the hepatic outflow was restored with an 8×20 mm Palmaz stent. At 12-month follow-up, his symptoms have resolved, and his liver tests are within normal limits. He remains on systemic anticoagulation.

  • Cardiovascular medicine
  • Interventional cardiology
  • Venous thromboembolism
  • Haematology (drugs and medicines)
  • Drugs and medicines

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors CAH contributed to the conception and design, planning, writing the manuscript and final approval.

    RL contributed to the acquisition of data, writing the manuscript and final approval.

    JEAA contributed to the acquisition of data, writing the manuscript, critical review and final approval.

    HLE contributed to the acquisition of data and final approval.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.